The Knowledge and Attitudes of the Public toward the Clinical Use of Artificial Intelligence

IF 0.4 Q4 PHARMACOLOGY & PHARMACY

Asian Journal of Pharmaceutics Pub Date : 2021-04-05 DOI:10.22377/AJP.V15I1.3974

Nehad J. Ahmed

{"title":"The Knowledge and Attitudes of the Public toward the Clinical Use of Artificial Intelligence","authors":"Nehad J. Ahmed","doi":"10.22377/AJP.V15I1.3974","DOIUrl":null,"url":null,"abstract":"Aim: This study aims to explore the knowledge and attitudes of the public toward the clinical use of artificial intelligence. Materials and Methods: This is a cross-sectional study that included an online questionnaire. The data were collected and analyzed using Excel software and represented as frequencies and percentages. Results: More than 55% of the respondents said that they had heard of artificial intelligence in medicine but only 3.17% said that they know about artificial intelligence in medicine completely. More than 89% of the respondents said that they prefer the suggestions from human doctor to take when diagnosis diverges. Moreover, only 25.34% of them believe in the therapeutic advice made by an artificial intelligence doctor independently. Conclusion: The present study showed that a high percentage of the public was not trust the use of artificial intelligence because they fear that artificial intelligence could cause fatal errors. Further studies are needed to ensure the efficacy of artificial intelligence doctor before the implementation and after that help patients in understanding the benefits and the risk of artificial intelligence use.","PeriodicalId":8489,"journal":{"name":"Asian Journal of Pharmaceutics","volume":"1 1","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2021-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Pharmaceutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22377/AJP.V15I1.3974","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 1

Abstract

Aim: This study aims to explore the knowledge and attitudes of the public toward the clinical use of artificial intelligence. Materials and Methods: This is a cross-sectional study that included an online questionnaire. The data were collected and analyzed using Excel software and represented as frequencies and percentages. Results: More than 55% of the respondents said that they had heard of artificial intelligence in medicine but only 3.17% said that they know about artificial intelligence in medicine completely. More than 89% of the respondents said that they prefer the suggestions from human doctor to take when diagnosis diverges. Moreover, only 25.34% of them believe in the therapeutic advice made by an artificial intelligence doctor independently. Conclusion: The present study showed that a high percentage of the public was not trust the use of artificial intelligence because they fear that artificial intelligence could cause fatal errors. Further studies are needed to ensure the efficacy of artificial intelligence doctor before the implementation and after that help patients in understanding the benefits and the risk of artificial intelligence use.

查看原文本刊更多论文

公众对人工智能临床应用的认知与态度

目的:本研究旨在探讨公众对人工智能临床应用的认知和态度。材料和方法:这是一项横断面研究，包括一份在线问卷。数据收集和分析使用Excel软件，并表示为频率和百分比。结果:超过55%的受访者表示听说过医学领域的人工智能，但只有3.17%的受访者表示完全了解医学领域的人工智能。超过89%的受访者表示，当诊断出现分歧时，他们更愿意接受人类医生的建议。此外，只有25.34%的人相信人工智能医生独立给出的治疗建议。结论:目前的研究表明，很高比例的公众不相信人工智能的使用，因为他们担心人工智能可能会导致致命的错误。为了确保人工智能医生在实施前的疗效，以及在实施后帮助患者了解使用人工智能的益处和风险，还需要进一步的研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Asian Journal of Pharmaceutics PHARMACOLOGY & PHARMACY-

自引率

0.00%

发文量

期刊介绍： Character of the publications: -Pharmaceutics and Pharmaceutical Technology -Formulation Design and Development -Drug Discovery and Development Interface -Manufacturing Science and Engineering -Pharmacokinetics, Pharmacodynamics, and Drug Metabolism -Clinical Pharmacology, General Medicine and Translational Research -Physical Pharmacy and Biopharmaceutics -Novel Drug delivery system -Biotechnology & Microbiological evaluations -Regulatory Sciences